New Cytokines as Potential Drugs

Robert Coffman

ISBN 10: 3764358831 / ISBN 13: 9783764358839

Published by Birkhäuser Basel Feb 2000, 2000

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Over the past ten years, a number of cytokines and growth factors haveproven to be as effective therapeutics. While these products havecertainly established recombinant biologics as a major pharmaceuticalgrowth sector, the continued interest in this class of drugs arises fromthe fact that today we have a far better understanding of the humanimmune response, both at a cellular and molecular level.This has resulted in a more methodical characterisation of these factorswhich has given clinical researchers an opportunity to plan Phase 1clinical trials that can provide substantial information on the activityof the cytokine in humans. Currently, a great deal of effort is alsobeing channelled into identifying cytokines from the various DNAdatabases.Our major objective for this book is to profile cytokines that have beenrecently identified. The therapeutic potential of these cytokines basedon their known properties will be discussed by the authors. The main aimof this book is to provide. 156 pp. Englisch.

Seller Inventory # 9783764358839

Bibliographic Details

• Title: New Cytokines as Potential Drugs
• Publisher: Birkhäuser Basel Feb 2000
• Publication Date: 2000
• Language: English
• ISBN 10: 3764358831
• ISBN 13: 9783764358839
• Binding: Buch
• Condition: Neu
• Dimensions: 241W x 160H x 15D millimeters 241 millimeters width by 160 millimeters height by 15 millimeters depth
• Weight: 407 grams

About this title

Synopsis

Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide...